Close Menu

NEW YORK – With a fresh $121 million in financing from its recent Series A funding round, proteomics firm Somalogic is looking to expand its SomaScan platform business and continue its push into the diagnostics space.

The Boulder, Colorado-based company is working to make assays run on its SomaScan system more streamlined and cost-efficient and more easily deployable in sites like hospital labs while also continue to expand the menu of proteins the platform is able to measure, said CEO Roy Smythe.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.